Neoleukin Therapeutics (NLTX) Stock Chart & Stock Price History → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free NLTX Stock Alerts $31.55 +0.91 (+2.97%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Neoleukin Therapeutics Stock Price Performance5 Day Performance-5.00%1 Month Performance+126.00%3 Month Performance+5.17%6 Month Performance+128.62%Year-To-Date Performance+62.80%1 Year Performance+82.37% Receive NLTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Monetary GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. NLTX Stock Chart for Wednesday, May, 15, 2024 NLTX Chart by TradingView Neoleukin Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$32.50$30.64-5.72%$33.20$29.5447,541 shs$287.96 million05/13/2024$32.50$32.50$34.67$32.2728,093 shs$305.44 million05/10/2024$33.21$33.21$33.87$32.9431,505 shs$312.11 million05/09/2024$32.90$33.21+0.94%$33.87$32.9431,505 shs$312.11 million05/08/2024$33.94$32.90-3.06%$34.90$32.0060,719 shs$309.19 million05/07/2024$32.81$33.94+3.44%$34.46$32.1371,992 shs$318.97 million Get the Latest News and Ratings for NLTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$36.63$32.81-10.43%$37.59$32.4661,305 shs$308.35 million05/03/2024$35.39$35.39$35.53$32.9478,640 shs$332.60 million05/02/2024$34.48$35.39+2.64%$35.53$32.9478,640 shs$32.80 million05/01/2024$33.40$34.48+3.23%$35.10$33.27155,575 shs$324.04 million04/30/2024$33.40$33.40$33.54$31.37121,085 shs$313.89 million04/29/2024$29.96$33.40+11.48%$33.54$31.37121,084 shs$313.89 million04/26/2024$29.87$29.96+0.30%$31.52$29.8847,839 shs$281.56 million04/25/2024$31.17$29.87-4.17%$29.96$28.0971,109 shs$280.72 million04/24/2024$31.17$31.17$33.08$30.7058,205 shs$292.94 million04/23/2024$30.49$31.17+2.23%$33.08$30.7058,205 shs$292.94 million04/22/2024$30.49$30.49$32.44$29.9082,724 shs$286.55 million04/19/2024$31.58$31.58$33.81$30.85100,284 shs$296.79 million04/18/2024$35.20$31.58-10.28%$33.81$30.85100,284 shs$296.79 million04/17/2024$37.43$35.20-5.96%$37.46$34.95110,591 shs$330.81 million04/16/2024$13.96$37.43+168.12%$39.71$36.2588,805 shs$351.77 million04/15/2024$39.70$13.96-64.84%$14.36$13.6828,275 shs$131.20 million04/12/2024$38.33$38.33$40.41$37.94106,862 shs$360.23 million04/11/2024$40.96$38.33-6.42%$40.41$37.94106,862 shs$360.23 million04/10/2024$41.62$40.96-1.59%$42.71$40.6169,880 shs$384.94 million04/09/2024$41.31$41.62+0.75%$42.61$40.1048,837 shs$391.15 million04/08/2024$41.31$41.31$43.66$40.9378,856 shs$388.23 million04/05/2024$42.64$42.64$44.64$42.61320,826 shs$400.73 million04/04/2024$44.59$42.64-4.37%$44.64$42.61320,826 shs$400.73 million04/03/2024$46.78$44.59-4.68%$47.56$44.36102,153 shs$419.06 million04/02/2024$46.78$46.78$51.22$46.57337,770 shs$439.64 million04/01/2024$50.90$46.78-8.09%$51.22$46.57337,770 shs$439.64 million03/29/2024$50.90$50.90$52.50$46.69411,713 shs$478.36 million03/28/2024$49.26$50.90+3.33%$52.50$46.69346,901 shs$478.36 million03/27/2024$49.45$49.26-0.38%$50.72$48.6298,679 shs$462.95 million03/26/2024$49.03$49.45+0.86%$50.65$48.1880,598 shs$464.73 million03/25/2024$49.88$49.03-1.70%$52.66$48.72211,691 shs$460.78 million03/22/2024$49.22$49.88+1.34%$53.00$48.69215,800 shs$468.77 million03/21/2024$44.80$49.22+9.87%$49.58$45.28197,742 shs$462.57 million03/20/2024$37.55$44.80+19.31%$46.80$43.63211,487 shs$421.03 millionBill Clinton Backing Biden Replacement??? (Ad)Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast.03/19/2024$37.53$37.55+0.05%$38.50$36.55272,831 shs$352.90 million03/18/2024$37.53$37.53$38.11$34.31643,857 shs$352.71 million03/15/2024$34.56$34.56$35.97$33.11167,289 shs$324.80 million03/14/2024$36.06$34.56-4.16%$35.97$33.11167,284 shs$324.80 million03/13/2024$36.45$36.06-1.07%$37.00$35.37147,925 shs$338.89 million03/12/2024$36.45$36.45$38.97$36.1464,452 shs$342.56 million03/11/2024$37.25$36.45-2.15%$38.97$36.1464,452 shs$342.56 million03/08/2024$37.98$38.68+1.84%$39.93$37.5463,850 shs$363.52 million03/07/2024$37.24$37.98+1.99%$38.94$37.2661,248 shs$356.94 million03/06/2024$38.55$37.24-3.40%$40.18$37.1185,405 shs$349.98 million03/05/2024$32.00$38.55+20.47%$39.95$32.00299,772 shs$362.29 million03/04/2024$32.00$32.00$32.06$30.58131,935 shs$300.74 million03/01/2024$30.70$31.07+1.21%$31.48$30.5433,020 shs$292.00 million02/29/2024$32.44$30.70-5.36%$33.00$30.0582,068 shs$288.52 million02/28/2024$30.44$32.44+6.57%$32.88$29.27191,665 shs$304.87 million02/27/2024$30.44$30.44$30.93$29.7677,634 shs$286.08 million02/26/2024$30.15$30.44+0.96%$30.93$29.7677,634 shs$286.08 million02/23/2024$30.29$30.29$30.45$29.6975,354 shs$284.67 million02/22/2024$29.80$30.29+1.64%$30.45$29.6975,354 shs$284.67 million02/21/2024$29.46$29.80+1.15%$30.36$29.00293,198 shs$280.06 million02/20/2024$29.46$29.46$30.01$29.0218,167 shs$276.87 million02/19/2024$29.46$29.46$30.01$29.0218,167 shs$276.87 million02/16/2024$30.00$30.00$30.42$29.1128,752 shs$281.94 million02/15/2024$29.91$30.00+0.30%$30.60$29.1929,522 shs$281.94 million02/14/2024$29.14$29.91+2.64%$30.68$28.1436,574 shs$281.09 million Related Companies: Vanda Pharmaceuticals Stock Price Chart CorMedix Stock Price Chart Organogenesis Stock Price Chart Kamada Stock Price Chart UroGen Pharma Stock Price Chart Verrica Pharmaceuticals Stock Price Chart Ventyx Biosciences Stock Price Chart Procaps Group Stock Price Chart Aquestive Therapeutics Stock Price Chart Atea Pharmaceuticals Stock Price Chart Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NLTX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldBill Clinton Backing Biden Replacement???The Freeport SocietyTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neoleukin Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.